Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor-Reference-Cited by-同舟云学术

Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor

Published:1993 Issue:3 Volume:25 Page:217-224
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Hackenberg Reinhard,Hawighorst Thomas,Filmer Angelika,Huschmand Nia Abdolhamid,Schulz Klaus-Dieter

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00689836.pdf

Reference34 articles.

1. Blossey HC, Wander HE, Köbberling J, Nagel GA: Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high dose medroxyprogesterone acetate. Cancer 54: 1208?1215, 1984

2. Becher R, Miller AA, Höffken K, Gerhold U, Hirche H, Schmidt CG: High-dose medroxyprogesterone-acetate in advanced breast cancer. Clinical and pharmakokinetic study with a combined oral and intramuscular regimen. Cancer 63: 1938?1943, 1989

3. Schulz K-D, Schmidt-Rhode P, Zippel HH, Sturm G: New concepts of adjuvant drug treatment in endometrial cancer. In: Schulz K-D, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, Munich, Vienna, San Francisco, 1987, pp 169?180

4. Hellman L, Yoshida K, Zumoff B, Levin J, Kream J, Fukushima DK: The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. J Clin Endocrinol Metab 42: 912?917, 1976

5. DiMarco A: The antitumor activity of 6-methyl-17-acetoxy progesterone (MPA) in experimental mammary cancer. In: Iacobelli S, DiMarco A (eds) Role of Medroxyprogesterone in endocrine-related tumors. Raven Press, New York, 1980, pp 1?20

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data;Molecular and Cellular Endocrinology;2019-01

2. Beyond the C18 frontier: Androgen and glucocorticoid metabolism in breast cancer tissues;Steroids;2015-11

3. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A);The Journal of Steroid Biochemistry and Molecular Biology;2014-09

4. Complexities of androgen receptor signalling in breast cancer;Endocrine-Related Cancer;2014-06-20

5. Tissue-specific bioconcentration of the synthetic steroid hormone medroxyprogesterone acetate in the common carp (Cyprinus carpio);Environmental Toxicology and Pharmacology;2013-11